Table 1.

Addition of cardiolipin in APTT-based LAC assay



Coagulation time

Ratio, patient to normal pool

Difference, ratio 25 μm CL—ratio 0 μm CL
Plasma
0 μm CL
25 μm CL
0 μm CL
25 μm CL
Normal pool plasma   37.4   38.6   NA   NA   NA  
Plasma with β2GPI-dependent LAC   69.0   57.0   B0/C0 = 1.84   B25/C25 = 1.48   -0.36  
Plasma with β2GPI-Independent LAC
 
72.5
 
79.2
 
A0/C0 = 1.91
 
A25/C25 = 2.05
 
0.14
 


Coagulation time

Ratio, patient to normal pool

Difference, ratio 25 μm CL—ratio 0 μm CL
Plasma
0 μm CL
25 μm CL
0 μm CL
25 μm CL
Normal pool plasma   37.4   38.6   NA   NA   NA  
Plasma with β2GPI-dependent LAC   69.0   57.0   B0/C0 = 1.84   B25/C25 = 1.48   -0.36  
Plasma with β2GPI-Independent LAC
 
72.5
 
79.2
 
A0/C0 = 1.91
 
A25/C25 = 2.05
 
0.14
 

Plasmas of 2 patients were diluted 1:1 with normal pool plasma and incubated with different concentrations of cardiolipin and reagent (Diagnostica Stago). As a reference we performed the same assay with normal pool plasma. An LAC was characterized as β2-GPI dependent when the ratio of patient plasma divided by normal plasma decreased by at least 0.05 at 25 μM cardiolipin compared with no addition of cardiolipin. Coagulation was initiated by the addition of CaCl2, and clotting time was measured.

NA indicates not applicable.

or Create an Account

Close Modal
Close Modal